5-Fluorouracil (5-FU)
Bioavailability Study of Oral 5-Fluorouracil in Colorectal Cancer Patients.
... of 5-Fluorouracil (5-FU) when given with skimmed milk in colorectal cancer ...Oral 5-FU (500 mg/m 2 ) was administered with skimmed milk (250 ml) to colorectal cancer ...
10
DEVELOPMENT AND IN VITRO EVALUATION OF FLOATING MICROSPHERES OF 5 FLUOROURACIL
... 5-Fluorouracil (5-FU) is an antimetabolite of the pyrimidine analog class, which is widely used alone or in combination chemotherapy regimens in a variety of solid cancers, such as stomach, ...
8
Retrospective analysis of chronomodulated chemotherapy versus conventional chemotherapy with paclitaxel, carboplatin, and 5-fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
... and 5-fluorouracil (5-Fu) can signifi- cantly improve efficacy and reduce the incidence of adverse events in patients with metastatic colorectal cancer, as compared with conventional ...
8
Calotropis gigantea Leaf Extract Increases the Efficacy of 5-Fluorouracil and Decreases the Efficacy of Doxorubicin in Widr Colon Cancer Cell Culture
... drug 5-Fluorouracil (5-FU) and doxorubicin against WiDR colon cancer ...and 5-Fluorouracil gives synergism effect at the dose combination of EDCG+5FU (3 µg/ml + ...of 5 ...
6
Augmentation of 5-aminolevulinic Acid Treatment of Glioblastoma by Adding Ciprofloxacin, Deferiprone, 5-fluorouracil and Febuxostat: The CAALA Regimen
... four 5-ALA augmentation drugs are ciprofloxacin, a broad spectrum antibiotic; deferiprone, an iron chelating drug; 5-fluorouracil (5-FU), an antimetabolite in use to treat colon or ...
35
Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5 fluorouracil
... 33]. 5-Fluorouracil (5-FU), a clinically well-established medication, is administered either systemically for the treatment of colorectal, stomach and breast cancers or topically for skin ...
13
The Anti Proliferative Effect of 5 Fluorouracil on Tumor Is Highly Associated with the Renewal of Peripheral White Blood Cells
... thymine, 5-FU is competitively incorporated into DNA double chains when DNA replicates during the S phase of the cell cycle and lead to cell death ...of 5-FU on cycling cells is usually ...
7
Metformin mediates resensitivity to 5-fluorouracil in hepatocellular carcinoma via the suppression of YAP
... to 5-fluorouracil (5-Fu) in vitro and in vivo, and the combination of metformin and 5-Fu inhibited cell proliferation, promoted cell apoptosis and induced G0/G1 cell cycle arrest ...
12
Pre-treatment evaluation of 5-fluorouracil degradation rate: association of poor and ultra-rapid metabolism with severe toxicity in a colorectal cancer patients cohort
... of 5-fluorouracil-based chemotherapy, development of severe toxicity that follow the treatment is not a rare ...named 5-fluorauracil degradation rate, presents a normal distribution inside the ...
9
5-Fluorouracil for the treatment of intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva, and cornea
... of 5-FU was given in the subconjunctival tissues after biopsy was ...topical 5-FU four times daily for 4 days, for six treatment ...1% 5-FU eye ...
8
Clinical significance of the thymidylate synthase, dihydropyrimidine dehydrogenase, and thymidine phosphorylase mRNA expressions in hepatocellular carcinoma patients receiving 5-fluorouracil-based transarterial chemoembolization treatment
... Taken together, high DPD mRNA expression is associ- ated with poor treatment outcome in HCC patients treated with 5-FU-based TACE, which may be a predictive marker for treatment resistance of ...
8
Eukaryotic translation initiation factor 3 subunit G (EI F3G) resensitized HC T116/5-Fu to 5-fluorouracil (5-Fu) via inhibition of MRP and MDR1
... control, 5-Fu administration, and 5-Fu administration with eiF3g shrna1 stably transfected hcT116/5-Fu cells at various time points (days ...showed 5-Fu sensitive ...
10
Interpreting clinical assays for histone deacetylase inhibitors
... Abbreviaions: 5-aza, 5-aza-cytidine; 5-azaDc, 5-aza-2′-deoxycytidine; 5-FU, 5-fluorouracil; 13-cis-RA, 13-cis-retinoic acid; ALL, acute lymphoblastic leukemia; AMC, ...
25
Patient-derived xenografts: a relevant preclinical model for drug development
... and 5-Fluorouracil (5-FU), given also in com- bination therapy with the monoclonal antibody Trastuzu- ...was 5/7 as they showed that among clinical cases, two clinical responses were ...
8
Download Download PDF
... activity. 5 Fluorouracil (5-FU) and cyclophosphamide (Cf) are drugs widely used in solid tumors and in bone marrow transplantation, ...with 5-FU+leucovorin (LV) at 20 and 10mg/Kg ...
7
Journal of Applied Pharmaceutical Science
... using 5-fluorouracil (5-FU) as a drug ...released 5-FU was monitoring as an antiproliferative agent against human liver cancer cell line (HEPG2) as well as antimicrobial against ...
10
Mutations in Coronavirus Nonstructural Protein 10 Decrease Virus Replication Fidelity
... mutagen 5-fluorouracil (5-FU) than wild-type (WT)-ExoN(ⴙ), sug- gestive of decreased replication ...logs, 5-azacytidine and ...in 5-FU sensitivity was observed for ...
9
Arsenic trioxide reverses the chemoresistance in hepatocellular carcinoma: a targeted intervention of 14–3-3η/NF-κB feedback loop
... pathways. 5-fluoro- uracil is a thymidylate synthase inhibitor and its metabo- lites can be incorporated into DNA, thus influence cell proliferation ...sides, 5-fluorouracil, oxaliplatin and ...
11
Chemoradiation versus oesophagectomy for locally advanced oesophageal cancer in Chinese patients: study protocol for a randomised controlled trial
... Concurrent chemoradiotherapy (CRT) as a neoadju- vant therapy has preferable clinical efficacy and has be- come the standard treatment for local advanced EC with recognised guidelines [10–12]. Compared with chemo- ...
8
Case Report Long-term complete response in supraclavicular lymph node metastases of esophageal cancer using systemic chemotherapy-a case report
... Esophageal cancer is one of the most common and refractory malignant diseases, and its inci- dence has been increasing in recent years [1-4]. Statistical data indicates that about 482,300 new esophageal cancer cases and ...
6